For the vaccination of the 15-18 years age group, only Covaccine is expected to be available for the time being. The interval between the second and third doses of the Covid-19 vaccine can be nine to 12 months.
Covid preventive vaccination (to be given to the age group of adolescents 15-18 years of three January next year Covid 19 Vaccine just Bharat Biotech (to) Bharat Biotech ) vaccine 'Covaksin' ( Covaxin likely to be available) Is. Government sources have given this information. With this, health and frontline workers and people above 60 years of age suffering from serious illness will be given the third dose of the same vaccine as the first two doses have been given to them.
Adolescents will also get corona vaccine
Let us inform, Prime Minister Narendra Modi had announced in a message to the nation on Saturday night that from January 3, an anti-Covid vaccination campaign will be started for adolescents in the age group of 15-18 years, while from January 10, health and frontline workers will be ' 'Precautionary dose' i.e. the third dose will be applied.
Omicron's decision amid the growing threat
The decision comes amid a surge in Covid cases related to the 'Omicron' form of the virus. Bharat Biotech's 'Covaccine' is currently the only anti-Covid-19 vaccine that will be administered to adolescents aged 15-18 years from January 3, a government source said.
Not yet included in 'Jacov-D' vaccination program
He said that the estimated population in this category is seven to eight crores. Sources said that Zydus Cadila's vaccine 'Jacov-D' has not been included in the country's vaccination program so far, even for the adult population. However, it was approved by the Drug Controller for emergency use on August 20, making it the first vaccine in the country that can be administered to the age group of 12-18 years.
What is the interval between the second and third doses?
The interval between the second and third doses of the Covid-19 vaccine can be nine to 12 months. Necessary changes are being made on the Covin portal so that a new category of vaccination can be registered.
Covaccine for children over 12 years old
The Drug Controller General of India (DCGI) on Friday approved the indigenously developed Covaccine vaccine for emergency use on children above the age of 12 years but also imposed some conditions.
